StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note published on Thursday morning. The brokerage issued a hold rating on the software maker’s stock.
Separately, Stephens increased their target price on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
View Our Latest Report on Veradigm
Veradigm Trading Up 1.0 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- What Are Treasury Bonds?
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
